Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by A. Feican
Pms24 - Cost Minimization Analysis of Third Line Rheumatoid Arthritis Drugs in Ecuador
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Impact of Price Regulation of Biologic Therapies for Rheumatoid Arthritis in Colombia – A Cost Minimization Analysis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cost-Effectiveness Analysis of Tocilizumab Subcutaneouscombotherapy First Line for the Management of Rheumatoid Arthritis in Greece
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cost-Minimization Analysis of Anti-TNF Biologics in the Treatment of Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriatic Arthritis Under the Brazilian Private Health Care System Perspective
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Safety, Cost and Effectiveness Issues With Disease Modifying Anti-Rheumatic Drugs in Rheumatoid Arthritis
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Anti-Inflammatory Drugs for Rheumatoid Arthritis
BMJ
Cost Effectiveness of TNF-αInhibitors in Rheumatoid Arthritis
International Journal of Inflammation
Allergy
Immunology
Pms44 - Cost-Effectiveness Analysis of Subcutaneous Tocilizumab Plus Methotrexate in Rheumatoid Arthritis Treatment
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pms56 - Cost-Effectiveness Analysis of Subcutaneous Tocilizumab Without Methotrexate in Rheumatoid Arthritis Treatment
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cost-Effectiveness of Adalimumab for Rheumatoid Arthritis in Germany
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
